Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-01

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The optimal interval between pregnancies is debated, but a duration greater than 11-18 months has been suggested as reducing complications in the subsequent pregnancy. Improved birth spacing can be a key benefit use of long-acting reversible contraception, but delay to initiation can still be problematic.So women who have recently given birth can be cost-effectively targeted for family planning education and engagement because often they are already connected with health professionals

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery

NCT00476021

Contraception

COMPLETED NA

Patient Compliance With Long-Acting Reversible Contraception Administration

NCT03305081

Contraception

TERMINATED NA

Discontinuation Rate Among Copper IUD Users

NCT03404102

Contraceptive Device; Intrauterine

UNKNOWN

Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial

NCT01272960

Postpartum Period

COMPLETED NA

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

NCT02067663

Contraception

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraception Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

insertion by the end of the 4th week postpartum

Group Type EXPERIMENTAL

early insertion

Intervention Type PROCEDURE

insertion at 4th postpartum week

insertion by the end of the 6th week postpartum

Group Type ACTIVE_COMPARATOR

late insertion

Intervention Type PROCEDURE

insertion at 6th postpartum week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

early insertion

insertion at 4th postpartum week

Intervention Type PROCEDURE

late insertion

insertion at 6th postpartum week

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Delivered (vaginal or Cesarean) a singleton living baby ≥28weeks gestation. Women desire birth spacing for one year or more. Women who will accept to participate in the study and follow up.

Exclusion Criteria

1. Known uterine anomalies.
2. Women with previous ectopic pregnancy.
3. Presence of postpartum pyrexia.
4. Women with history of postpartum hemorrhage in the last delivery either primary or secondary.
5. Retained products of conception.
6. History of previous uterine perforation.
7. Anticipation of difficulty of subsequent follow-up with the women.
8. Women with uncontrolled diabetes and hypertension.
9. Women who wish to use other contraceptive methods.

Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No